A Case of Coronvirus Disease 2019 With Psychological Disorders

Chen, Jiaxiang; Tian, Chong; Cheng, Xiaokun; Huang, Ying; Tang, Lei; Wang, Rongpin; Zeng, Xian‐Chun

doi:10.24869/psyd.2020.581

Cited by 3 publications

(9 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Most of the studies had been conducted in China ( n = 15) ( 30 , 33 , 34 , 45 , 50 , 52–55 , 63 , 64 , 66–69 ), Iran ( n = 6) ( 38 , 47 , 48 , 58 , 61 , 62 ), Italy ( n = 5) ( 29 , 31 , 41 , 44 , 57 ), India ( n = 4) ( 36 , 46 , 56 , 59 ), United States ( n = 2) ( 28 , 35 ), and Korea ( n = 2) ( 49 , 65 ). The remaining studies had been developed in Saudi Arabia ( n = 1) ( 27 ), Nigeria ( n = 1) ( 32 ), Indonesia ( n = 1) ( 39 ), France ( n = 1) ( 42 ), Turkey ( n = 1) ( 43 ), Thailand ( n = 1) ( 51 ), Latvia ( n = 1) ( 40 ), Ghana ( n = 1) ( 37 ), and Poland ( n = 1) ( 60 ).…”

Section: Resultsmentioning

confidence: 99%

“…On the one hand, some studies focused on mildly-affected patients, namely participants who had recovered from COVID-19 symptoms ( n = 5) ( 31 , 32 , 38 , 47 , 59 ), who were asymptomatic ( n = 2) ( 39 , 56 ), presented mild COVID-19 symptoms ( n = 2) ( 54 , 55 ) or were out of hospital ( n = 3) ( 48 , 58 , 61 ). On the other hand, other interventions had been provided to COVID-19 patients who were hospitalized in isolation wards ( n = 20) ( 29 , 30 , 33–37 , 43 , 46 , 49–53 , 60 , 63–66 , 68 ) or patients with severe symptoms in Intensive Care Units ( n = 3) ( 42 , 66 , 67 ). Additional researches recruited participants from various settings and with different levels of severity of COVID-19 symptoms ( n = 3) ( 41 , 45 ) or did not specify the severity of the COVID-19 symptoms ( n = 3) ( 27 , 57 , 69 ).…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Guiding future research on psychological interventions in people with COVID-19 and post COVID syndrome and comorbid emotional disorders based on a systematic review

Martínez-Borba,

Martínez-García,

Peris-Baquero

et al. 2024

Front. Public Health

View full text Add to dashboard Cite

ObjectiveThe COVID-19 pandemic has been emotionally challenging for the entire population and especially for people who contracted the illness. This systematic review summarizes psychological interventions implemented in COVID-19 and long COVID-19 patients who presented comorbid emotional disorders.Methods and measures3,839 articles were identified in 6 databases and 43 of them were included in this work. Two independent researchers selected the articles and assessed their quality.Results2,359 adults were included in this review. Severity of COVID-19 symptoms ranged from asymptomatic to hospitalized patients; only 3 studies included long COVID-19 populations. Similar number of randomized controlled studies (n = 15) and case studies (n = 14) were found. Emotional disorders were anxiety and/or depressive symptoms (n = 39) and the psychological intervention most represented had a cognitive behavioral approach (n = 10). Length of psychological programs ranged from 1–5 sessions (n = 6) to 16 appointments (n = 2). Some programs were distributed on a daily (n = 4) or weekly basis (n = 2), but other proposed several sessions a week (n = 4). Short (5–10 min, n = 4) and long sessions (60–90 min, n = 3) are proposed. Most interventions were supported by the use of technologies (n = 18). Important risk of bias was present in several studies.ConclusionPromising results in the reduction of depressive, anxiety and related disorders have been found. However, important limitations in current psychological interventions were detected (i.e., duration, format, length, and efficacy of interventions were not consistently established across investigations). The results derived from our work may help to understand clinical practices in the context of pandemics and could guide future efforts to manage emotional suffering in COVID-19 patients. A stepped model of care could help to determine the dosage, length and format of delivery for each patient.Systematic review registration: PROSPERO 2022 CRD42022367227. Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022367227

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Guiding future research on psychological interventions in people with COVID-19 and post COVID syndrome and comorbid emotional disorders based on a systematic review

Martínez-Borba,

Martínez-García,

Peris-Baquero

et al. 2024

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…When screening the results found by the Ovid COVID-19 Limit for Tables 6-7, the authors found potentially relevant references that were missed due to spelling errors, for instance, "coronvirus" (Chen et al, 2020) or "Sarss-Cov2" (Angel Mejia, Arango Isaza, Fernandez Turizo, Vasquez Trespalacios, & Rincon, 2021).…”

Section: Spelling and Formatting Issuesmentioning

confidence: 99%

“…Note that three of these references have subsequently been indexed with headings that are retrieved by the NICE strategy (Chen et al, 2020;Seco et al, 2020;Vogel, 2020).…”

Section: Spelling and Formatting Issuesmentioning

confidence: 99%

The NICE COVID-19 search strategy for Ovid MEDLINE and Embase: developing and maintaining a strategy to support rapid guidelines

Levay

Finnegan

2021

Preprint

View full text Add to dashboard Cite

Introduction The United Kingdom's (UK) National Institute for Health and Care Excellence (NICE) needs access to evidence on COVID-19 to develop rapid guidelines for healthcare professionals. This paper reports on how the NICE COVID-19 search strategy for identifying references in Ovid MEDLINE and Embase has been developed and maintained. Methods Each free-text line from the June 2020 version of the NICE COVID-19 search strategy was categorised as Critical, High, Medium, Low or Zero priority, according to the number of results and their relevance to NICE. Five search options were devised and tested by combining them with a search for drug treatments. The two prioritised options were compared to the COVID-19 Limit available in Ovid. New subject headings were tested and added. The selected option was refined to make the strategy simpler to use. Results The updated strategy combines free-text terms, categorised as Critical, High and Medium priority for NICE, with appropriate subject headings. Discussion The paper describes the challenges of maintaining a search strategy during the COVID-19 pandemic, as terminology continues to evolve. Conclusions A search strategy for identifying COVID-19 references, within the remit of NICE, has been developed. The recommended strategy could be considered for validation at an appropriate point in the pandemic. It is hoped that understanding how NICE has maintained its COVID-19 strategy will encourage further discussion on the challenges.

show abstract

“…This last application field has become a great challenge in view of the development of novel functional textile materials that have been accelerated in the pandemic context caused by SARS-CoV-2 during 2020 and presently. Due to the rapid and great mass mobilization of people across the planet, the emergence of the SARS-CoV-2 virus managed to be transmitted very effectively in the human population, bringing not only mortality but also psychological alterations to the surviving individuals [33,34]. The current world pandemic situation demands smart antiviral/antimicrobial textiles for protective healthcare professionals and individuals able to be adapted to the new normality.…”

Section: Introductionmentioning

confidence: 99%

Development and Characterization of Antimicrobial Textiles from Chitosan-Based Compounds: Possible Biomaterials Against SARS-CoV-2 Viruses

Favatela

Otarola

Ayala-Peña

et al. 2022

J Inorg Organomet Polym

View full text Add to dashboard Cite

Novel antiviral cotton fabrics impregnated with different formulations based on Chitosan (CH), citric acid (CA), and Copper (Cu) were developed. CA was selected as a CH crosslinker agent and Cu salts as enhancers of the polymer antimicrobial activity. The characterization of the polymeric-inorganic formulations was assessed by using atomic absorption spectroscopy, X-ray diffraction, Fourier transform infrared and UV-Vis spectroscopy, as well as thermogravimetric analysis. The achieved data revealed that CuO nanoparticles were formed by means of chitosan and citric acid in the reaction media. The antiviral activity of CH-based formulations against bovine alphaherpesvirus and bovine betacoronavirus was analyzed. Cotton fabrics were impregnated with the selected formulations and the antiviral properties of such textiles were examined before and after 5 to 10 washing cycles. Herpes simplex virus type 1 was selected to analyze the antiviral activities of the functionalized cotton fabrics. The resulting impregnated textiles exhibited integrated properties of good adhesion without substantially modifying their appearance and antiviral efficacy (~ 100%), which enabling to serve as a scalable biocidal layer in protective equipment's by providing contact killing against pathogens. Thus, the results revealed a viable contribution to the design of functional-active materials based on a natural polymer such as chitosan. This proposal may be considered as a potential tool to inhibit the propagation and dissemination of enveloped viruses, including SARS-CoV-2.

show abstract

A Case of Coronvirus Disease 2019 With Psychological Disorders

Cited by 3 publications

References 0 publications

Guiding future research on psychological interventions in people with COVID-19 and post COVID syndrome and comorbid emotional disorders based on a systematic review

Guiding future research on psychological interventions in people with COVID-19 and post COVID syndrome and comorbid emotional disorders based on a systematic review

The NICE COVID-19 search strategy for Ovid MEDLINE and Embase: developing and maintaining a strategy to support rapid guidelines

Development and Characterization of Antimicrobial Textiles from Chitosan-Based Compounds: Possible Biomaterials Against SARS-CoV-2 Viruses

Contact Info

Product

Resources

About